ENTITY

Chunghwa Chemical Synthesis & Biotech (1762 TT)

2

Analysis

Health Care • Taiwan

Chunghwa Chemical Synthesis & Biotech Co Ltd is a biomedical company. The Company contract manufactures a wide range of pharmaceutical products, including pain management, antifungal, immunosuppressant, as well as provides synthesis and biotechnology technologies.

more

Refresh

Exchange Announcement • 20 Nov 2024 15:47

Announcement Related To The Change Of Business Location Of The Company'S Stock Affairs Agency "Yuanta Securities Co., Ltd. Registrar & Transfer Department"

Exchange Announcement • 12 Nov 2024 19:49

Announcement Of The Board Of Directors Resolved To Donate To Wang Ming-Ning Memorial Foundation.

Exchange Announcement • 11 Nov 2024 17:04

Announce The Company'S 2024q3 Consolidated Financial Reports Approved By The Board Of Directors.

Exchange Announcement • 01 Nov 2024 14:25

Announcement For The Expected Date Of The Board Of Directors Meeting For 2024 Third Quarter Consolidated Financial Statements Is 2024/11/11

Exchange Announcement • 23 Aug 2024 17:05

Ccsb Is Invited To Attend The Online Investor Conference Held By Yuanta Securities.

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.4

x